mitoxantrone has been researched along with Fibrous Histiocytoma of Tendon Sheath in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noguchi, R | 1 |
| Yoshimatsu, Y | 1 |
| Ono, T | 1 |
| Sei, A | 1 |
| Hirabayashi, K | 1 |
| Ozawa, I | 1 |
| Kikuta, K | 1 |
| Kondo, T | 1 |
1 other study available for mitoxantrone and Fibrous Histiocytoma of Tendon Sheath
| Article | Year |
|---|---|
Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.
Topics: Adult; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Collagen Type VI; Female; Gefiti | 2021 |